Novartis transfers Australian medications distribution

Wednesday, June 07, 2017

Novartis has confirmed that after June 30 ophthalmic medications, dry eye and allergy eye products will no longer be distributed by subsidiary company, Alcon.

Instead, Novartis, which has been managing distribution in Australia since April 1, indicated products such as Systane and Artificial Tears will be available through third party distributor Clifford Hallam Healthcare (CH2).

Other Alcon Vision Care products, such as contact lenses and the Opti-free range, are not impacted by the change and can still be ordered through the usual channels.

According to a release from franchise director of ophthalmology at Novartis, Mr Marco Muscardo, CH2 was selected as a preferred distributor due to its online ordering tool and willingness to maintain existing pricing agreements.

“CH2 will continue to offer special pricing arrangements that you may have agreed to with Alcon in relation to the Transferring Products. As an introductory offer (and in order to facilitate the ongoing supply of products to you) CH2 is offering a credit of $100 (ex GST) on all new accounts opened prior to 1 July 2017 and redeemable until 30 June 2018 for the purchase of Transferring Products,” he stated.

CH2 is said to have an extensive national distribution network supplying pharmacies and optometrists including throughout regional Australia.